During the past decade, Jichi Medical University Hospital conducted 67 clinical trials. In the 10-year time frame, 67 clinical trials started and 34 clinical trials were completed, i.e. on average, 50.7% percent of trials that started reached the finish line to date. In the past 5 years, 34 clinical trials started and 24 clinical trials were completed. i.e. 70.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jichi Medical University Hospital" #1 sponsor was "Eli Lilly and Company" with 8 trials, followed by "Pfizer" with 8 trials sponsored, "Takeda" with 6 trials sponsored, "Amgen" with 5 trials sponsored and "Boehringer Ingelheim" with 5 trials sponsored. Other sponsors include 57 different institutions and companies that sponsored additional 44 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jichi Medical University Hospital" #1 collaborator was "Boehringer Ingelheim" with 3 trials as a collaborator, "Incyte Corporation" with 2 trials as a collaborator, "Japan Lung Cancer Society" with 2 trials as a collaborator, "NPO International TRI Network" with 2 trials as a collaborator and "Takara Bio Inc." with 2 trials as a collaborator. Other collaborators include 21 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Jichi Medical University Hospital" are "Hypertension" (6 trials), "Psoriasis" (5 trials), "Ulcerative Colitis" (4 trials), "Colorectal Cancer" (3 trials) and "Crohn's Disease" (3 trials). Many other conditions were trialed in "Jichi Medical University Hospital" in a lesser frequency.

Most popular intervention types in "Jichi Medical University Hospital" are "Drug" (69 trials), "Device" (10 trials), "Biological" (7 trials), "Other" (7 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (19 trials), "Apremilast" (4 trials), "BMS-986165" (4 trials), "Baricitinib" (3 trials) and "Mirikizumab" (3 trials). Other intervention names were less common.

The vast majority of trials in "Jichi Medical University Hospital" are 87 trials for "All" genders, 6 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Jichi Medical University Hospital". undefined are not yet recruiting, 20 are recruiting, 18 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 47 completed trials in Jichi Medical University Hospital, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Jichi Medical University Hospital, 6 "Phase 1" clinical trials were conducted, 20 "Phase 2" clinical trials and 51 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".